Former President Donald Trump’s imposition of tariffs on imports from Canada and Mexico, citing their alleged failure to curb the flow of fentanyl into the United States, has drawn scrutiny as data reveals a more complex picture of the crisis. The tariffs, announced in early February 2026, initially targeted a 10% levy on goods from China, which was implemented, while tariffs on Mexico and Canada were temporarily suspended pending negotiations.
The justification for the tariffs rests on the claim that these countries are not adequately preventing the smuggling of fentanyl and its precursor chemicals. However, data from U.S. Customs and Border Patrol indicates that a negligible percentage – approximately 0.8% – of fentanyl seizures occur at the Canadian border. The vast majority of seizures grab place at the U.S.-Mexico border, a point acknowledged by the White House.
Fentanyl, a synthetic opioid initially developed in the 1950s and introduced for medical use in the 1960s, is now a primary driver of opioid overdose deaths in the U.S. The drug is approved by the Food and Drug Administration for pain management and anesthesia and is significantly more potent than morphine – estimated to be 50 to 100 times stronger. While pharmaceutical fentanyl remains a legitimate medical tool, the surge in overdose deaths is overwhelmingly linked to illicitly manufactured fentanyl (IMF).
The crisis has evolved over time. Originally, illicit fentanyl and its chemical components were shipped directly from China to the United States. However, the supply chain has become increasingly diffuse, with China remaining the primary source of precursor chemicals. These chemicals are then used to produce fentanyl, often in clandestine labs, and smuggled into the U.S. Primarily through Mexico.
The illicit fentanyl frequently appears in two forms: as a powder, or pressed into counterfeit pills designed to resemble legitimate prescription opioids. This deceptive practice poses a significant risk to users who may be unaware they are consuming a potentially lethal substance. As little as two milligrams of fentanyl – roughly the size of a pencil tip – can be fatal.
The U.S. Centers for Disease Control and Prevention (CDC) reported over 48,000 deaths in 2024 attributed to drug mixtures containing fentanyl. This figure underscores the scale of the public health crisis and the challenges facing law enforcement and policymakers.
The White House has accused both Canada and Mexico of failing to adequately address the flow of fentanyl into the U.S., but the data suggests the primary entry point remains the southern border. Negotiations with Mexico regarding border security are ongoing, with the threat of increased tariffs remaining on the table. Canada has pledged to bolster border security measures, but the effectiveness of these measures remains to be seen.
The tariffs on Chinese goods, however, remain in effect, despite the fact that the illicit fentanyl supply chain has evolved beyond direct shipments from China. The administration maintains that China bears responsibility for supplying the precursor chemicals that fuel the illicit fentanyl trade. As of February 10, 2026, the Chinese government has not issued a formal response to the tariffs.
